6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLO[3,2-B]PYRIDINE
Product Information
Molecular Formula
C13H17BN2O2
Molecular Weight
262.11256
Description
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[3,2-b]pyridine is a very effective and versatile compound. The field of biomedicine focuses on the effective eradication of different types of tumors. This extraordinary drug works as an outstanding targeted therapy, carefully inhibiting the action of enzymes that promote tumor development and malignancy.
Synonyms
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[3,2-b]pyridine; 1H-PYRROLO[3,2-B]PYRIDINE-6-BORONIC ACID PINACOL ESTER; (1h-pyrrolo[3,2-b]pyridin-6-yl)boronic acid pinacol ester; 6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrrolo[3,2-b]pyridine; 1H-Pyrrolo[3,2-B]pyridine-6-boronicacidpinacolester; 6-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[3,2-b]pyridine; 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[3,2-b]pyridine
IUPAC Name
6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[3,2-b]pyridine
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC3=C(C=CN3)N=C2
InChI
InChI=1S/C13H17BN2O2/c1-12(2)13(3,4)18-14(17-12)9-7-11-10(16-8-9)5-6-15-11/h5-8,15H,1-4H3
InChI Key
LVVACKKTPDWXJM-UHFFFAOYSA-N
Flash Point
Not applicable
Purity
95%
Computed Properties
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
1
Exact Mass
244.1383080 g/mol
Monoisotopic Mass
244.1383080 g/mol
Topological Polar Surface Area
47.1Ų
Heavy Atom Count
18
Formal Charge
0
Complexity
319
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021249913-A9 | 2'-(quinolin-3-yl)-5',6'-dihydrospiro[azetidine-3,4'-pyrrolo[1,2-b]pyrazole]-1-carboxylate derivatives and related compounds as map4k1 (hpk1) inhibitors for the treatment of cancer | 2020-06-09 |
| JP-2020502092-A | Bicyclo [1.1.1] pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease | 2016-12-08 |
| EP-3538518-A1 | Substituted quinoxaline derivatives as inhibitors of pfkfb | 2016-11-08 |
| IL-266121-D0 | Quincosalin history is conserved as pfkfb inhibitor | 2016-11-08 |
| JP-2019532998-A | Substituted quinoxaline derivatives as PFKFB inhibitors | 2016-11-08 |
| US-2019256499-A1 | Substituted quinoxaline derivatives as inhibitors of pfkfb | 2016-11-08 |
| WO-2018087021-A1 | Substituted quinoxaline derivatives as inhibitors of pfkfb | 2016-11-08 |
| JP-2019533687-A | Pyrazole amide compounds as IRAK inhibitors | 2016-10-26 |
| US-10414753-B2 | Amide compounds and method for making and using | 2016-10-26 |
| US-2018111917-A1 | Amide compounds and method for making and using | 2016-10-26 |
